Loading…
Loss of retinal ganglion cells in a new genetic mouse model for primary open‐angle glaucoma
Primary open‐angle glaucoma (POAG) is one of the most common causes for blindness worldwide. Although an elevated intraocular pressure (IOP) is the main risk factor, the exact pathology remained indistinguishable. Therefore, it is necessary to have appropriate models to investigate these mechanisms....
Saved in:
Published in: | Journal of cellular and molecular medicine 2019-08, Vol.23 (8), p.5497-5507 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4763-795c94ce0444594e199de8389558abbe568064760bcc151b78e250a05d13f1a03 |
---|---|
cites | cdi_FETCH-LOGICAL-c4763-795c94ce0444594e199de8389558abbe568064760bcc151b78e250a05d13f1a03 |
container_end_page | 5507 |
container_issue | 8 |
container_start_page | 5497 |
container_title | Journal of cellular and molecular medicine |
container_volume | 23 |
creator | Reinehr, Sabrina Koch, Dennis Weiss, Maximilian Froemel, Franziska Voss, Christina Dick, H. Burkhard Fuchshofer, Rudolf Joachim, Stephanie C. |
description | Primary open‐angle glaucoma (POAG) is one of the most common causes for blindness worldwide. Although an elevated intraocular pressure (IOP) is the main risk factor, the exact pathology remained indistinguishable. Therefore, it is necessary to have appropriate models to investigate these mechanisms. Here, we analysed a transgenic glaucoma mouse model (βB1‐CTGF) to elucidate new possible mechanisms of the disease. Therefore, IOP was measured in βB1‐CTGF and wildtype mice at 5, 10 and 15 weeks of age. At 5 and 10 weeks, the IOP in both groups were comparable (P > 0.05). After 15 weeks, a significant elevated IOP was measured in βB1‐CTGF mice (P |
doi_str_mv | 10.1111/jcmm.14433 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6653331</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2232481391</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4763-795c94ce0444594e199de8389558abbe568064760bcc151b78e250a05d13f1a03</originalsourceid><addsrcrecordid>eNp9kcFuEzEURS1ERUtgwwcgS2wQUoo9z3bGG6QqotAqFRtYIsvjvBkm8tjBzlB1xyf0G_kSPCStgEW9sC35-Oq-ewl5wdkpL-vtxg3DKRcC4BE54bKu5kKDeHy48xrqY_I05w1joDjoJ-QYeMGFYCfk6yrmTGNLE-76YD3tbOh8HwN16H2mfaCWBrymHYZCODrEMWPZ1-hpGxPdpn6w6YbGLYZfP2-n30g7b0cXB_uMHLXWZ3x-OGfky_n7z8uP89WnDxfLs9XciYWC-UJLp4VDVjxJLZBrvcZiW0tZ26ZBqWqmCska57jkzaLGSjLL5JpDyy2DGXm3192OzYBrh2GXrDcHbyba3vz7Evpvpos_jFISAHgReH0QSPH7iHlnhj5PCdiAZWBTVVCJuoQ3oa_-QzdxTCW6QgmtNFOsSD5EAVdQV1AKm5E3e8qlUkPC9t4yZ2bq1kzdmj_dFvjl30Peo3dlFoDvgeve480DUuZyeXW1F_0NSsiueA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2316382344</pqid></control><display><type>article</type><title>Loss of retinal ganglion cells in a new genetic mouse model for primary open‐angle glaucoma</title><source>Open Access: PubMed Central</source><source>Wiley_OA刊</source><source>ProQuest - Publicly Available Content Database</source><creator>Reinehr, Sabrina ; Koch, Dennis ; Weiss, Maximilian ; Froemel, Franziska ; Voss, Christina ; Dick, H. Burkhard ; Fuchshofer, Rudolf ; Joachim, Stephanie C.</creator><creatorcontrib>Reinehr, Sabrina ; Koch, Dennis ; Weiss, Maximilian ; Froemel, Franziska ; Voss, Christina ; Dick, H. Burkhard ; Fuchshofer, Rudolf ; Joachim, Stephanie C.</creatorcontrib><description>Primary open‐angle glaucoma (POAG) is one of the most common causes for blindness worldwide. Although an elevated intraocular pressure (IOP) is the main risk factor, the exact pathology remained indistinguishable. Therefore, it is necessary to have appropriate models to investigate these mechanisms. Here, we analysed a transgenic glaucoma mouse model (βB1‐CTGF) to elucidate new possible mechanisms of the disease. Therefore, IOP was measured in βB1‐CTGF and wildtype mice at 5, 10 and 15 weeks of age. At 5 and 10 weeks, the IOP in both groups were comparable (P > 0.05). After 15 weeks, a significant elevated IOP was measured in βB1‐CTGF mice (P < 0.001). At 15 weeks, electroretinogram measurements were performed and both the a‐ and b‐wave amplitudes were significantly decreased in βB1‐CTGF retinae (both P < 0.01). Significantly fewer Brn‐3a+ retinal ganglion cells (RGCs) were observed in the βB1‐CTGF group on flatmounts (P = 0.02), cross‐sections (P < 0.001) and also via quantitative real‐time PCR (P = 0.02). Additionally, significantly more cleaved caspase 3+ RGCs were seen in the βB1‐CTGF group (P = 0.002). Furthermore, a decrease in recoverin+ cells was observable in the βB1‐CTGF animals (P = 0.004). Accordingly, a significant down‐regulation of Recoverin mRNA levels were noted (P < 0.001). Gfap expression, on the other hand, was higher in βB1‐CTGF retinae (P = 0.023). Additionally, more glutamine synthetase signal was noted (P = 0.04). Although no alterations were observed regarding photoreceptors via immunohistology, a significant decrease of Rhodopsin (P = 0.003) and Opsin mRNA (P = 0.03) was noted. We therefore assume that the βB1‐CTGF mouse could serve as an excellent model for better understanding the pathomechanisms in POAG.</description><identifier>ISSN: 1582-1838</identifier><identifier>ISSN: 1582-4934</identifier><identifier>EISSN: 1582-4934</identifier><identifier>DOI: 10.1111/jcmm.14433</identifier><identifier>PMID: 31144440</identifier><language>eng</language><publisher>England: John Wiley & Sons, Inc</publisher><subject>Animal models ; Animals ; Antibodies ; Blindness ; Caspase-3 ; Connective tissue growth factor ; Disease Models, Animal ; Down-Regulation - physiology ; electroretinogram ; Electroretinography - methods ; Female ; Glaucoma ; Glaucoma, Open-Angle - metabolism ; Glaucoma, Open-Angle - pathology ; Glial Fibrillary Acidic Protein - metabolism ; Glutamate-ammonia ligase ; Glutamine ; Immunoglobulins ; Intraocular pressure ; Male ; Mice ; mRNA ; Original ; Photoreceptors ; primary open‐angle glaucoma ; Recoverin ; Retina ; Retina - metabolism ; Retina - pathology ; Retinal ganglion cells ; Retinal Ganglion Cells - metabolism ; Retinal Ganglion Cells - pathology ; Rhodopsin ; Risk factors ; RNA, Messenger - metabolism ; Software ; Studies ; βB1‐CTGF</subject><ispartof>Journal of cellular and molecular medicine, 2019-08, Vol.23 (8), p.5497-5507</ispartof><rights>2019 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.</rights><rights>2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4763-795c94ce0444594e199de8389558abbe568064760bcc151b78e250a05d13f1a03</citedby><cites>FETCH-LOGICAL-c4763-795c94ce0444594e199de8389558abbe568064760bcc151b78e250a05d13f1a03</cites><orcidid>0000-0001-7056-0829</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2316382344/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2316382344?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,11562,25753,27924,27925,37012,37013,44590,46052,46476,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31144440$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Reinehr, Sabrina</creatorcontrib><creatorcontrib>Koch, Dennis</creatorcontrib><creatorcontrib>Weiss, Maximilian</creatorcontrib><creatorcontrib>Froemel, Franziska</creatorcontrib><creatorcontrib>Voss, Christina</creatorcontrib><creatorcontrib>Dick, H. Burkhard</creatorcontrib><creatorcontrib>Fuchshofer, Rudolf</creatorcontrib><creatorcontrib>Joachim, Stephanie C.</creatorcontrib><title>Loss of retinal ganglion cells in a new genetic mouse model for primary open‐angle glaucoma</title><title>Journal of cellular and molecular medicine</title><addtitle>J Cell Mol Med</addtitle><description>Primary open‐angle glaucoma (POAG) is one of the most common causes for blindness worldwide. Although an elevated intraocular pressure (IOP) is the main risk factor, the exact pathology remained indistinguishable. Therefore, it is necessary to have appropriate models to investigate these mechanisms. Here, we analysed a transgenic glaucoma mouse model (βB1‐CTGF) to elucidate new possible mechanisms of the disease. Therefore, IOP was measured in βB1‐CTGF and wildtype mice at 5, 10 and 15 weeks of age. At 5 and 10 weeks, the IOP in both groups were comparable (P > 0.05). After 15 weeks, a significant elevated IOP was measured in βB1‐CTGF mice (P < 0.001). At 15 weeks, electroretinogram measurements were performed and both the a‐ and b‐wave amplitudes were significantly decreased in βB1‐CTGF retinae (both P < 0.01). Significantly fewer Brn‐3a+ retinal ganglion cells (RGCs) were observed in the βB1‐CTGF group on flatmounts (P = 0.02), cross‐sections (P < 0.001) and also via quantitative real‐time PCR (P = 0.02). Additionally, significantly more cleaved caspase 3+ RGCs were seen in the βB1‐CTGF group (P = 0.002). Furthermore, a decrease in recoverin+ cells was observable in the βB1‐CTGF animals (P = 0.004). Accordingly, a significant down‐regulation of Recoverin mRNA levels were noted (P < 0.001). Gfap expression, on the other hand, was higher in βB1‐CTGF retinae (P = 0.023). Additionally, more glutamine synthetase signal was noted (P = 0.04). Although no alterations were observed regarding photoreceptors via immunohistology, a significant decrease of Rhodopsin (P = 0.003) and Opsin mRNA (P = 0.03) was noted. We therefore assume that the βB1‐CTGF mouse could serve as an excellent model for better understanding the pathomechanisms in POAG.</description><subject>Animal models</subject><subject>Animals</subject><subject>Antibodies</subject><subject>Blindness</subject><subject>Caspase-3</subject><subject>Connective tissue growth factor</subject><subject>Disease Models, Animal</subject><subject>Down-Regulation - physiology</subject><subject>electroretinogram</subject><subject>Electroretinography - methods</subject><subject>Female</subject><subject>Glaucoma</subject><subject>Glaucoma, Open-Angle - metabolism</subject><subject>Glaucoma, Open-Angle - pathology</subject><subject>Glial Fibrillary Acidic Protein - metabolism</subject><subject>Glutamate-ammonia ligase</subject><subject>Glutamine</subject><subject>Immunoglobulins</subject><subject>Intraocular pressure</subject><subject>Male</subject><subject>Mice</subject><subject>mRNA</subject><subject>Original</subject><subject>Photoreceptors</subject><subject>primary open‐angle glaucoma</subject><subject>Recoverin</subject><subject>Retina</subject><subject>Retina - metabolism</subject><subject>Retina - pathology</subject><subject>Retinal ganglion cells</subject><subject>Retinal Ganglion Cells - metabolism</subject><subject>Retinal Ganglion Cells - pathology</subject><subject>Rhodopsin</subject><subject>Risk factors</subject><subject>RNA, Messenger - metabolism</subject><subject>Software</subject><subject>Studies</subject><subject>βB1‐CTGF</subject><issn>1582-1838</issn><issn>1582-4934</issn><issn>1582-4934</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><recordid>eNp9kcFuEzEURS1ERUtgwwcgS2wQUoo9z3bGG6QqotAqFRtYIsvjvBkm8tjBzlB1xyf0G_kSPCStgEW9sC35-Oq-ewl5wdkpL-vtxg3DKRcC4BE54bKu5kKDeHy48xrqY_I05w1joDjoJ-QYeMGFYCfk6yrmTGNLE-76YD3tbOh8HwN16H2mfaCWBrymHYZCODrEMWPZ1-hpGxPdpn6w6YbGLYZfP2-n30g7b0cXB_uMHLXWZ3x-OGfky_n7z8uP89WnDxfLs9XciYWC-UJLp4VDVjxJLZBrvcZiW0tZ26ZBqWqmCska57jkzaLGSjLL5JpDyy2DGXm3192OzYBrh2GXrDcHbyba3vz7Evpvpos_jFISAHgReH0QSPH7iHlnhj5PCdiAZWBTVVCJuoQ3oa_-QzdxTCW6QgmtNFOsSD5EAVdQV1AKm5E3e8qlUkPC9t4yZ2bq1kzdmj_dFvjl30Peo3dlFoDvgeve480DUuZyeXW1F_0NSsiueA</recordid><startdate>201908</startdate><enddate>201908</enddate><creator>Reinehr, Sabrina</creator><creator>Koch, Dennis</creator><creator>Weiss, Maximilian</creator><creator>Froemel, Franziska</creator><creator>Voss, Christina</creator><creator>Dick, H. Burkhard</creator><creator>Fuchshofer, Rudolf</creator><creator>Joachim, Stephanie C.</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7056-0829</orcidid></search><sort><creationdate>201908</creationdate><title>Loss of retinal ganglion cells in a new genetic mouse model for primary open‐angle glaucoma</title><author>Reinehr, Sabrina ; Koch, Dennis ; Weiss, Maximilian ; Froemel, Franziska ; Voss, Christina ; Dick, H. Burkhard ; Fuchshofer, Rudolf ; Joachim, Stephanie C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4763-795c94ce0444594e199de8389558abbe568064760bcc151b78e250a05d13f1a03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animal models</topic><topic>Animals</topic><topic>Antibodies</topic><topic>Blindness</topic><topic>Caspase-3</topic><topic>Connective tissue growth factor</topic><topic>Disease Models, Animal</topic><topic>Down-Regulation - physiology</topic><topic>electroretinogram</topic><topic>Electroretinography - methods</topic><topic>Female</topic><topic>Glaucoma</topic><topic>Glaucoma, Open-Angle - metabolism</topic><topic>Glaucoma, Open-Angle - pathology</topic><topic>Glial Fibrillary Acidic Protein - metabolism</topic><topic>Glutamate-ammonia ligase</topic><topic>Glutamine</topic><topic>Immunoglobulins</topic><topic>Intraocular pressure</topic><topic>Male</topic><topic>Mice</topic><topic>mRNA</topic><topic>Original</topic><topic>Photoreceptors</topic><topic>primary open‐angle glaucoma</topic><topic>Recoverin</topic><topic>Retina</topic><topic>Retina - metabolism</topic><topic>Retina - pathology</topic><topic>Retinal ganglion cells</topic><topic>Retinal Ganglion Cells - metabolism</topic><topic>Retinal Ganglion Cells - pathology</topic><topic>Rhodopsin</topic><topic>Risk factors</topic><topic>RNA, Messenger - metabolism</topic><topic>Software</topic><topic>Studies</topic><topic>βB1‐CTGF</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Reinehr, Sabrina</creatorcontrib><creatorcontrib>Koch, Dennis</creatorcontrib><creatorcontrib>Weiss, Maximilian</creatorcontrib><creatorcontrib>Froemel, Franziska</creatorcontrib><creatorcontrib>Voss, Christina</creatorcontrib><creatorcontrib>Dick, H. Burkhard</creatorcontrib><creatorcontrib>Fuchshofer, Rudolf</creatorcontrib><creatorcontrib>Joachim, Stephanie C.</creatorcontrib><collection>Wiley_OA刊</collection><collection>Wiley-Blackwell Open Access Backfiles</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Science Database (ProQuest)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of cellular and molecular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Reinehr, Sabrina</au><au>Koch, Dennis</au><au>Weiss, Maximilian</au><au>Froemel, Franziska</au><au>Voss, Christina</au><au>Dick, H. Burkhard</au><au>Fuchshofer, Rudolf</au><au>Joachim, Stephanie C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Loss of retinal ganglion cells in a new genetic mouse model for primary open‐angle glaucoma</atitle><jtitle>Journal of cellular and molecular medicine</jtitle><addtitle>J Cell Mol Med</addtitle><date>2019-08</date><risdate>2019</risdate><volume>23</volume><issue>8</issue><spage>5497</spage><epage>5507</epage><pages>5497-5507</pages><issn>1582-1838</issn><issn>1582-4934</issn><eissn>1582-4934</eissn><abstract>Primary open‐angle glaucoma (POAG) is one of the most common causes for blindness worldwide. Although an elevated intraocular pressure (IOP) is the main risk factor, the exact pathology remained indistinguishable. Therefore, it is necessary to have appropriate models to investigate these mechanisms. Here, we analysed a transgenic glaucoma mouse model (βB1‐CTGF) to elucidate new possible mechanisms of the disease. Therefore, IOP was measured in βB1‐CTGF and wildtype mice at 5, 10 and 15 weeks of age. At 5 and 10 weeks, the IOP in both groups were comparable (P > 0.05). After 15 weeks, a significant elevated IOP was measured in βB1‐CTGF mice (P < 0.001). At 15 weeks, electroretinogram measurements were performed and both the a‐ and b‐wave amplitudes were significantly decreased in βB1‐CTGF retinae (both P < 0.01). Significantly fewer Brn‐3a+ retinal ganglion cells (RGCs) were observed in the βB1‐CTGF group on flatmounts (P = 0.02), cross‐sections (P < 0.001) and also via quantitative real‐time PCR (P = 0.02). Additionally, significantly more cleaved caspase 3+ RGCs were seen in the βB1‐CTGF group (P = 0.002). Furthermore, a decrease in recoverin+ cells was observable in the βB1‐CTGF animals (P = 0.004). Accordingly, a significant down‐regulation of Recoverin mRNA levels were noted (P < 0.001). Gfap expression, on the other hand, was higher in βB1‐CTGF retinae (P = 0.023). Additionally, more glutamine synthetase signal was noted (P = 0.04). Although no alterations were observed regarding photoreceptors via immunohistology, a significant decrease of Rhodopsin (P = 0.003) and Opsin mRNA (P = 0.03) was noted. We therefore assume that the βB1‐CTGF mouse could serve as an excellent model for better understanding the pathomechanisms in POAG.</abstract><cop>England</cop><pub>John Wiley & Sons, Inc</pub><pmid>31144440</pmid><doi>10.1111/jcmm.14433</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-7056-0829</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1582-1838 |
ispartof | Journal of cellular and molecular medicine, 2019-08, Vol.23 (8), p.5497-5507 |
issn | 1582-1838 1582-4934 1582-4934 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6653331 |
source | Open Access: PubMed Central; Wiley_OA刊; ProQuest - Publicly Available Content Database |
subjects | Animal models Animals Antibodies Blindness Caspase-3 Connective tissue growth factor Disease Models, Animal Down-Regulation - physiology electroretinogram Electroretinography - methods Female Glaucoma Glaucoma, Open-Angle - metabolism Glaucoma, Open-Angle - pathology Glial Fibrillary Acidic Protein - metabolism Glutamate-ammonia ligase Glutamine Immunoglobulins Intraocular pressure Male Mice mRNA Original Photoreceptors primary open‐angle glaucoma Recoverin Retina Retina - metabolism Retina - pathology Retinal ganglion cells Retinal Ganglion Cells - metabolism Retinal Ganglion Cells - pathology Rhodopsin Risk factors RNA, Messenger - metabolism Software Studies βB1‐CTGF |
title | Loss of retinal ganglion cells in a new genetic mouse model for primary open‐angle glaucoma |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T05%3A57%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Loss%20of%20retinal%20ganglion%20cells%20in%20a%20new%20genetic%20mouse%20model%20for%20primary%20open%E2%80%90angle%20glaucoma&rft.jtitle=Journal%20of%20cellular%20and%20molecular%20medicine&rft.au=Reinehr,%20Sabrina&rft.date=2019-08&rft.volume=23&rft.issue=8&rft.spage=5497&rft.epage=5507&rft.pages=5497-5507&rft.issn=1582-1838&rft.eissn=1582-4934&rft_id=info:doi/10.1111/jcmm.14433&rft_dat=%3Cproquest_pubme%3E2232481391%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4763-795c94ce0444594e199de8389558abbe568064760bcc151b78e250a05d13f1a03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2316382344&rft_id=info:pmid/31144440&rfr_iscdi=true |